Endocyte, Inc. News
Dow Trades Lower on Rates Fears, Tech Shares Sink Nasdaq
Stocks fall sharply on Thursday after a hawkish set of minutes from last month's Federal Reserve meeting cements the case for near-term interest rate hikes.
Novartis Snaps up Prostate Cancer Treatment with Endocyte Deal
The Swiss drugmaker will pay $2.1 billion for Endocyte, justifying the Nasdaq-listed biotech's pivot to prostate treatment last year.
Facebook, Fed Minutes, AmEx, PayPal and Endocyte - 5 Things You Must Know
U.S. stock futures decline after a hawkish set of minutes from last month's Federal Reserve meeting; American Express, PayPal and Travelers report earnings; Facebook believes hack was done by spammers, says a report; Novartis to buy Endocyte for $2.1 billion.
Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years
Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?
Heavy Trading On Endocyte (ECYT) Before Market Open
Trade-Ideas LLC identified Endocyte (ECYT) as a pre-market mover with heavy volume candidate
Endocyte (ECYT) Showing Signs Of A Dead Cat Bounce Today
Trade-Ideas LLC identified Endocyte (ECYT) as a "dead cat bounce" (down big yesterday but up big today) candidate
'Big Short' Burry Warns That a Repeat of the 2008 Crisis Is in Sight
The legendary financier reiterates his warnings of a market collapse on the way.
McDonald's Menu Adds a (Very) New Take on an Old Favorite
The fast-food giant has been hesitant to make changes like this, but Wendy's bold move may have forced it to.
Everything Elon Musk Said At Tesla AI Day to Sell His Vision
The billionaire wants to create a "future of abundance" by mass-producing humanoid robots.